WHC is still in active development. Read this to understand our approach.
depiction of CYQFCXCEBYINGO-UHFFFAOYSA-N.svg
tripsit

marinol

Check on tripsit

isomerdesign

THC

Check on isomerdesign

isomerdesign

cis-Δ9-THC

Check on isomerdesign

isomerdesign

inverse-Δ9-THC

Check on isomerdesign

pubchem

Dronabinol

Check on pubchem

druglab

Cannabis

Check on druglab

drugmap

Marinol

Check on drugmap

wiki

Tetrahydrocannabinol

Check on wiki

wiki

Cis-THC

Check on wiki

Data

InChI: InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3

Synonyms: delta(sup 9)-Thc, CAT-310,UNII-7J8897W37S, (L)-delta1-Tetrahydrocannabinol, Fish oils, n-3 fatty acid-high,.DELTA.1-Tetrahydrocannabinol,(6AR,10AR)-6,6,9-TRIMETHYL-3-PENTYL-6A,7,8,10A-TETRAHYDRO-6H-DIBENZO(B,D)PYRAN-1-OL, Delta9-trans-Tetrahydrocannabinol,BIDD:GT0427, Delta(sup 1)-Thc,L-.delta.1-trans-Tetrahydrocannabinol,δ9--tetrahydrocannabinol,(-)-Delta9-Tetrahydrocannabinol (Delta9-THC) 100 microg/mL in Methanol,L-trans-delta9-Tetrahydrocannabinol,NSC134454,6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol,(-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol(l)-delta(sup 1)-Tetrahydrocannabinol,delta(9)-Tetrahydrocannabinol, delta(sup 1)-Thc,(-)-delta9-Tetrahydrocannabinol,delta9-thc,D00306,Dronabinol,L-.delta.1-Tetrahydrocannabinol, (-)-DELTA1-Tetrahydrocannabinol,delta9-Tetrahydrocannabinol, Trans-delta9-Tetrahydrocannabinol,DRONABINOL [USP MONOGRAPH], Delta9-THC,DRONABINOL [HSDB],delta(9)-THC, DELTA1-Tetrahydrocannabinol,.DELTA.1-THC, delta1-Tetrahydrocannabinol, DRG-0138,DTXCID101327,(-)-trans-.DELTA.9-Tetrahydrocannabinol,GTPL2424,Dronabinolum,9-tetrahydrocannabinol, Cannabis resin, Promega, delta(1)-Tetrahydrocannabinol,(-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol, (-)-DELTA9-Tetrahydrocannabinol,delta(sup 1)-Thc,DRONABINOL [USAN], (-)-trans-delta9-Tetrahydrocannabinol,(-)-Delta9-THC (Dronabinol) 1.0 mg/ml in Methanol, Pro-Mega, SP 104,.DELTA.9-trans-Tetrahydrocannabinol,SCI-110 component dronabinol, Dronabinol (USP/INN), Delta(sup 9)-Tetrahydrocannabinol,6465-30-1,(l)-delta(sup 1)-Tetrahydrocannabinol,δ9-thc,L-trans-.delta.9-Tetrahydrocannabinol,ABBOTT-40566,Δ9-THC,(-)-.DELTA.9-Tetrahydrocannabinol,CAS-1972-08-3, 1972/8/3,CCRIS 4726, Delta(9)-Tetrahydrocannabinol,Cannabinol, delta1-tetrahydro-, (-)-delta(sup9)-trans-Tetrahydrocannabinol, Omega-3-Fatty acid, Delta(9)-THC, Delta-9-THC, SP,QCD-84924, Delta1-THC,DRONABINOL [INN], delta-9-THC,TETRAHYDROCANNABINOL,(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol,(6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol,7J8897W37S, 1-trans-delta9-Tetrahydrocannabinol,Compassia,delta(sup 9)-Tetrahydrocannabinol, delta(9)-THC,6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-,Dronabinol (USP/INN), (-)-delta9-(trans)-Tetrahydrocannabinol,DRONABINOL [VANDF],delta1-Tetrahydrocannabinol, Drona binol,3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol, Delta9-Tetrahydrocannabinol (VAN), (-)-delta1-Tetrahydrocannabinol, 9-ene-Tetrahydrocannabinol, delta9-THC,.delta.-9-THC,1-trans-delta-9-Tetrahydrocannabinol,(6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol,INT-0010,DRONABINOL [WHO-DD],dronabinol, L-delta1-Tetrahydrocannabinol,Dronabinol (Synthetic),QCD 84924,1-trans-delta9-Tetrahydrocannabinol,(-)-Delta9-Tetrahydrocannabinol (Delta9-THC) 1000 microg/mL in Methanol, Tetranabinex, Cannabinol, tetrahydro-(6CI),6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-,(-)-trans-delta9-Tetrahydrocannabinol,Δ1-THC, Delta-THC,Epitope ID:224552, delta(9)-Tetrahydrocannibinol,syndros,Cannabinol, 1-trans-delta(sup 9)-tetrahydro-,.DELTA.9-THC,6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol,(6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, (l)-delta1-Tetrahydrocannabinol, Dronabinolum,trans-delta9-Tetrahydrocannabinol,14C-.DELTA.1-Tetrahydrocannabinol, Delta9-Tetrahydrocannabinol solution,(-)-.DELTA.1-Tetrahydrocannabinol,J882F, THC, L-delta(sup 1)-tetrahydrocannabinol, (-)-3,4-trans-Delta1-Tetrahydrocannabinol,ZINC1530625, Delta(sup 9)-Thc, Compassia,Tox21_112616, (-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol, Dronabinolum [Latin],delta(9)-Tetrahydrocannibinol, 1-trans-delta(sup 9)-Tetrahydrocannabinol, 9-tetrahydrocannabinol,(-)-trans-Delta9-THC solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,delta-9-THC,DELTA9-THC, (-)-trans-Delta9-THC, Namisol, 1-trans-D9-Tetrahydrocannabinol,Tetrahydrocannabinol delta9,(-)-Delta9-THC (Dronabinol) 0.1 mg/ml in Methanol,Dronabinolum [Latin],thc,DSSTox_GSID_21327,delta9-THC, (-)-DELTA9-THC,Tetrahydrocannabinols (-)-delta1-3,4-trans-form,delta9-Tetrahydrocannabinol (VAN),1-trans-delta(sup9)-tetrahydrocannabinol,Tetrahydrocannabinols (-)-trans-.delta.9-form, Delta-9-tetrahydrocannabinol, Delta9-Tetrahydrocannabinol,US9416103, Delta9-THC, (-)-DELTA9-trans-Tetrahydrocannabinol,trans-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol,inverse-Δ9-THC, Cannabinol, Delta1-tetrahydro-(7CI), Delta(9)-Tetrahydrocannibinol, Sonergx,Syndros,(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol, Fats and Glyceridic oils, fish, n-3 fatty acid-high, Hashish,(-)-delta1-Tetrahydrocannabinol, MaxEPA,L-delta1-trans-Tetrahydrocannabinol,delta1-THC,(-)-(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol, Marincap, Tetrahydrocannabinol delta9,TETRAHYDROCANNABINOL, DELTA-9 TRANS, delta1-THC,DSSTox_CID_1327,BDBM50007391,Cannabinol, 1-trans-.delta.(sup9)-tetrahydro-, Delta(1)-THC, Trans-tetrahydrocannabinol,(l)-delta1-Tetrahydrocannabinol,Cannabinol, .DELTA.1-tetrahydro-,DELTA-9-TETRAHYDROCANNABINOL (CANNABIS SATIVA EXTRACT),CHEBI:66964,(-)-.DELTA.1-3,4-TRANS-TETRAHYDROCANNABINOL,C06972,delta-Tetrahydrocannabinol (THC),DTXSID001038830,6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-,delta-9-tetrahydrocannabinol,TCI, THC-delta-9,Relivar, 14C-DELTA1-Tetrahydrocannabinol,6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-,THC,(10R,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol,3ls4,Marinol, (l)-delta(sup 1)-Tetrahydrocannabinol, delta9-Tetrahydrocannabinol,(-)-delta9-trans-Tetrahydrocannabinol,CHEMBL465,(-)-.delta.(sup9)-trans-Tetrahydrocannabinol, Omegaven,(6AR,10AR)-6,6,9-TRIMETHYL-3-PENTYL-6H,6AH,7H,8H,10AH-BENZO[C]ISOCHROMEN-1-OL, DELTA1-THC,DRONABINOL [MART.], (-)-delta9-Tetrahydrocannabinol,1972-08-3,DB00470, Abbott 40566,Deltanyne,SP 104,DTXSID6021327, Delta(sup 1)-Tetrahydrocannabinol, 6H-Dibenzo,Delta9-Tetrahydrocannabinol solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis, (-)-delta9-trans-Tetrahydrocannabinol,Q190067,6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol(delta9-THC(delta9-tetrahydrocannabinol)), 1-trans-delta(sup9)-tetrahydrocannabinol,8,8-Dimethyl-11-methylene-5-pentyl-3,4,8a,9,10,11,12,12a-octahydro-2H,8H-1,7-dioxa-benzo[c]phenanthrene,trans-.DELTA.9-Tetrahydrocannabinol,1-trans-.delta.(sup9)-tetrahydrocannabinol, Trans-delta-9-Tetrahydrocannabinol,(+/-)-delta9-Tetrahydrocannabinol,Marinol (TN),trans-Δ9-THC,6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol(DeltaE-9-THC),TETRAHYDROCANNABINOLS (-)-TRANS-.DELTA.9-FORM [MI],delta(1)-Tetrahydrocannabinol,INT-0010/06,DEA No. 7369, QCD 84924,(-)-Delta9-Tetrahydrocannabinol solution, 1-trans-delta-9-Tetrahydrocannabinol,NSC-134454,(6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol,6H-dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-, Delta1-Tetrahydrocannabinol, DELTA9-trans-Tetrahydrocannabinol, delta-9-tetrahydrocannabinol,(-)-.DELTA.9-THC,DRG-0138,delta(sup 9)-Thc,cesamet, Deltanyne,delta 9-Tetrahydrocannabinol,(-)-.DELTA.9-trans-Tetrahydrocannabinol, (-)-trans-Delta1-Tetrahydrocannabinol,.delta.(sup9)-THC,Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol, TETRAHYDROCANNABINOL,(L)-.delta.1-Tetrahydrocannabinol,DRONABINOL [ORANGE BOOK],.delta.-9-tetrahydrocannabinol,6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, delta(9)-Tetrahydrocannabinol, Dronabinol [USAN:INN],Namisol, Trans-DELTA9-Tetrahydrocannabinol,BDBM60994,Synthetic THC in sesame oil / soft gelatin,delta(sup 1)-Tetrahydrocannabinol,6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-,Delta9-Tetrahydrocannabinol solution, ethanol solution, Relivar,SP-104,PDSP2_000714,HSDB 6471, Tetrahydrocannabinols (-)-delta1-3,4-trans-form,(-)-Delta9-THC (Dronabinol) 5.0 mg/ml in Methanol,delta1-Tetrahydrocannabinol (VAN),NSC 134454,6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo(b,d)pyran-1-ol,Dronabinol in sesame oil in soft gelatin capsule,.DELTA.9-Tetrahydrocannabinol, (-)-trans-DELTA9-Tetrahydrocannabinol, Fish oils, omega-3 fatty acid-high,Delta-9-Tetrahydrocannabinol, United States Pharmacopeia (USP) Reference Standard,Abbott 40566,(-)-trans-Delta1-Tetrahydrocannabinol,DSSTox_RID_76083,(-)-Delta9-Tetrahydrocannabinol solution, ~1 mg/mL in ethanol, analytical standard, for drug analysis,Cannabinol, tetrahydro- (6CI), Marinol (TN), L-trans-delta9-Tetrahydrocannabinol, Delta(1)-Tetrahydrocannabinol, Delta(sup9)-THC,Delta9-Tetrahydrocannabinol 250 microg/mL in Acetonitrile,(S)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol,(-)-3,4-trans-Delta1-Tetrahydrocannabinol,delta9-trans-Tetrahydrocannabinol,delta9-tetrahydrocannabinol,CAT-310,SCHEMBL4609, L-delta1-trans-Tetrahydrocannabinol,(-)-trans-Delta9-THC, 9-delta-Tetrahydrocannabinol,Tetrahydrocannabinol, Delta1-Tetrahydrocannabinol (VAN),1-trans-delta(sup 9)-Tetrahydrocannabinol, Delta(9)-tetrahydrocannabinol, Ganja,cis-Δ9-THC,Dronabinol [USAN:USP:INN],Cannabinol, Delta1-tetrahydro- (7CI),delta-9 Tetrahydrocannabinol


Estimated data

Solubility: -6.513 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 90.2% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.